Birgit Grund

Photo of Birgit Grund

Contact Me

School of Statistics
383 Ford Hall

224 Church Street SE

Educational Background & Specialties

Educational Background

  • Ph.D.: Statistics, Humboldt University, Berlin, Germany, 1987.


  • Design and analysis of clinical trials, in HIV, Ebola, and COVID-19
  • Design of experiments
  • Nonparametric curve estimation and smoothing methods
Courses Taught
  • Stat 8052 - Applied Statistical Methods II
  • Stat 5301 - Experimental Design
  • Stat 5021 - Introduction to Statistics
  • Bibliography: Grund, Birgit, Author. Link
  • Hoy J, Grund B, Roediger M, Ensrud KE, Brar I, Colebunders R, De Castro N, Johnson M, Sharma A, Carr A for the INSIGHT SMART Body Composition Substudy Group. Interruption or deferral of antiretroviral therapy reduces markers of bone turnover compared with continuous therapy: the SMART Body Composition Substudy. J Bone Min Res 2013; DOI 10.1002/jbmr.1861.
  • Grund B, Sabin C. Analysis of biomarker data: logs, odds ratios, and receiver operating characteristic curves. Current Opinion in HIV & AIDS.2010;5(6):473-9
  • Grund B, Peng G, Gibert C, Hoy J, Isaksson R, Shlay J, et al. Continuous antiretroviral therapy decreases bone mineral density. AIDS. 2009;23(12):1519-29
  • Wright E, Grund B, Robertson K, Brew B, Roediger M, Bain M, et al. Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons. Neurology. 2010;75(10):864-73
  • Martinez E, Visnegarwala F, Grund B, Thomas A, Gibert C, Shlay J, et al. The effects of intermittent, CD4-guided antiretroviral therapy on body composition and metabolic parameters. AIDS. 2010;24(3):353-63
  • El-Sadr W, Grund B, Neuhaus J, Babiker A, Cohen C, Darbyshire J, et al. Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy - a randomized trial. Annals of Internal Medicine. 2008;149(5):289-W62
  • Burman W, Grund B, Roedige M, Friedland G, Darhyshire J, Wu A, et al. The impact of episodic CD4 cell count-guided antiretroviral therapy on quality of life. JAIDS-Journal of Acquired Immune Deficiency Syndromes. 2008;47(2):185-93.
  • Burman W, Grund B, Neuhaus J, Douglas J, Friedland G, Telzak E, et al. Episodic antiretroviral therapy increases HIV transmission risk compared with continuous therapy: Results of a randomized controlled trial. JAIDS-Journal of Acquired Immune Deficiency Syndromes. 2008;49(2):142-50
  • Carr A, Grund B, Neuhaus J, El-Sadr W, Grandits G, Gibert C, et al. Asymptomatic myocardial ischaemia in HIV-infected adults. AIDS. 2008;22(2):257-67
  • Lundgren J, Babiker A, El-Sadr W, Emery S, Grund B, Neaton J, et al. Inferior clinical outcome of the CD4(+) cell count guided antiretroviral treatment interruption strategy in the SMART study: Role of CD4(+) cell counts and HIV RNA levels during follow-up. Journal of Infectious Diseases. 2008;197(8):1145-55.
  • NSF Career Grant